Show Summary Details
Page of


Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 June 2022

Chapter 2: Gynaecology

1 Lewis G (ed) (2007). Saving Mothers Lives: Reviewing maternal deaths to make motherhood safer 2003–5. London: CEMACH.’%20Lives%202003-05%20.pdf

2 Teilmann G et al. (2006). Increased risk of precocious puberty in internationally adopted children in Denmark. Pediatrics 118(2):e391–e399. this resource:

3 James RM, Guideline Development Group (2008). Management of cervical cancer: summary of SIGN guidelines. BMJ 336:41. PubMed ID: 18174599.

4 NICE (2004). Fertility: assessment and treatment for people with fertility problems (CG11). NICE.

5 Nevatte T et al. (2013). ISMPD consensus on the management of menstrual disorders. Arch Womens Ment Health 16(4):279–91. PubMed ID: 23624686.

6 Rapkin AJ et al. (1997). Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 90:709–14. PubMed ID: 9351749.

7 Berga SL (1998). Understanding premenstrual syndrome. Lancet 351:465. PubMed ID: 9482435.


9 RCOG (2011). The care of women requesting induced abortion (Evidence-based clinical guideline No. 7).

10 RCOG (2001). Further issues relating to late abortion, fetal viability and registration of births and deaths

11 RCOG (2010). Understanding how risk is discussed in healthcare (Patient information).

12 RCOG (2011). Cervical cerclage (Green-top Guideline No. 60).

13 RCOG (2006). The management of early pregnancy loss (Green-top Guideline No. 25).

14 RCOG (2005). Disposal following pregnancy loss before 24 weeks’ gestation (Good Practice No. 5).

15 Noble LS (2005). Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertil Steril 83:684–90. PubMed ID: 15749498.

16 Rai R et al. (1997). Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 314(7076):253–7. PubMed ID: 9022487.

17 RCOG (2011). Recurrent miscarriage, investigation and treatment of couples (Green-top Guideline No. 17).

18 RCOG (2011). The management of tubal pregnancy (Green-top Guideline No. 21).

19 Fisher RA et al. (2011). What a difference an egg makes. Lancet 378:1974. PubMed ID: 22130487.

20 RCOG (2003). Lower Genital Tract Neoplasia (Follow up to the 44th RCOG Study Group). London: RCOGFind this resource:

21 RCOG (2011). The management of vulval skin disorders (Green-top Guideline No. 58).



24 Morris M et al. (2001). Bacterial vaginosis: a public health review. BJOG 108(5):439–50. PubMed ID: 11368127.

25 RCOG (2005). The initial management of chronic pelvic pain (Green-top Guideline No. 41).

26 Tomlinson IP et al. (2002). Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Multiple Leiomyoma Consortium. Nat Genet 30:406–10. PubMed ID: 11865300.

27 Milton J. Paradise Lost. (Book VIII, starting at line 465).

28 Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit (2015, amended 2017). Barrier methods for contraception and STI prevention.

29 NICE (2012). Clinical knowledge summaries: contraception.!background

30 Stanback J (1999). Checklist for ruling out pregnancy among family-planning clients in primary care. Lancet 354(9178):566. PubMed ID: 10470704.

31 Faculty of Sexual and Reproductive Healthcare (2011, updated 2012). Emergency contraception.

32 Webb AM (2004). Emergency contraception: latest changes. J Fam Plann Reprod Health Care 30(1):7–9. PubMed ID: 15006303.

33 Faculty of Sexual and Reproductive Healthcare (2009). UK medical eligibility criteria for contraceptive use 2009.

34 MacGregor EA et al. (1998). Combined oral contraceptives, migraine and ischaemic stroke. Clinical and Scientific Committee of the Faculty of Family Planning and Reproductive Health Care and the Family Planning Association. Br J Fam Plann 24(2):55–60. PubMed ID: 9719712.

35 Mansour D (2005). Missed contraceptive pills and the critical pill-free interval. Lancet 365:1670–1. PubMed ID: 15894085.

36 RCOG (2010). Venous thromboembolism and hormonal contraception (Green-top guidance 40).

37 Dinger J (2007). The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation. Contraception 75:344–54. PubMed ID: 17434015.

38 NICE (2009). Hysteroscopic sterilisation by tubal cannulation and placement of intrafallopian implants (IPG 315).

39 Cook L et al. (2007). Vasectomy occlusion techniques for male sterilization. Cochrane Database Syst Rev 2:CD003991. PubMed ID: 17443535.

40 Cook LA et al. (2007). Scalpel versus no-scalpel incision for vasectomy. Cochrane Database Syst Rev 2:CD004112. PubMed ID: 17443540.

41 Luesley DM et al. (2006). Management of Vulval Cancer. London: RCOG.Find this resource:

42 NICE (2009). Balloon catheter insertion for Bartholin’s cyst or abscess (IPG 323).

43 RCOG (2002). Fetal and maternal risks of diethylstilboestrol exposure in pregnancy (RCOG Statement No. 2)





48 Spencer CP (1999). Endometrial assessment re-visited. Br J Obstet Gynaecol 106(7):623–32.

49 NICE (2011). The recognition and initial management of ovarian cancer (CG122).

50 RCOG (2011). Best practice in outpatient hysteroscopy (Green-top Guideline No. 59).